Literature DB >> 20933077

Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways.

Haiying Zhang1, Yiheng Liu, Meili Lao, Zhijian Ma, Xinan Yi.   

Abstract

Mitochondrial oxidative stress induced by reactive oxygen species (ROS) has been strongly associated with the pathogenesis of neurodegenerative disorders, including Alzheimer's disease (AD). We used mitochondrial transgenic neuronal cell cybrid models of sporadic AD (SAD), which overproduce ROS compared to control cybrids, to investigate the protective effects of puerarin, an isoflavone purified from Chinese herb radix of Pueraria lobata, on viability, endogenous ROS and intracellular signaling pathways. SAD cybrids had increased apoptosis and increased accumulation of ROS that was inhibited by puerarin. Western blotting demonstrated that SAD cybrids had increased basal activation of the caspase-3, p38 and c-Jun N-terminal kinase (JNK) that were inhibited by puerarin. Puerarin was also found to decrease Bax/Bcl-2 ratio. These results suggest that expression of SAD mitochondrial genes in cybrids activates oxidative-stress-related signaling pathways and reduces viability, and that the protective effects of puerarin inhibit oxidative-stress-induced apoptosis through down-regulation of Bax/Bcl-2 ratio, which blocks the activation of JNK, p38 and caspase-3. Therefore, puerarin may act as an intracellular ROS scavenger, and protect neurons against oxidative-stress-induced apoptosis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933077     DOI: 10.1016/j.exger.2010.09.013

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  34 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms.

Authors:  Tourandokht Baluchnejadmojarad; Seyed-Mahdi Mohamadi-Zarch; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2019-08-17       Impact factor: 3.584

3.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Effect of puerarin on transcriptome of astrocyte during oxygen-glucose deprivation/reoxygenation injury.

Authors:  Shuyong Wei; Jie Tong; Qiang Xue; Yang Liu; Xiaoyu Xu
Journal:  Mol Cell Biochem       Date:  2016-11-14       Impact factor: 3.396

5.  Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.

Authors:  Xueqi Gan; Shengbin Huang; Long Wu; Yongfu Wang; Gang Hu; Guangyue Li; Hongju Zhang; Haiyang Yu; Russell Howard Swerdlow; John Xi Chen; Shirley ShiDu Yan
Journal:  Biochim Biophys Acta       Date:  2013-11-16

Review 6.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 7.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

Authors:  R H Swerdlow; S Koppel; I Weidling; C Hayley; Y Ji; H M Wilkins
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-01       Impact factor: 3.622

8.  Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment.

Authors:  Md Ejaz Ahmed; Hayate Javed; Mohd Moshahid Khan; Kumar Vaibhav; Ajmal Ahmad; Andleeb Khan; Rizwana Tabassum; Farah Islam; Mohammed M Safhi; Fakhrul Islam
Journal:  Protoplasma       Date:  2013-01-23       Impact factor: 3.356

Review 9.  The next step of neurogenesis in the context of Alzheimer's disease.

Authors:  Hamid Reza Moradi; Vahid Hajali; Zabihollah Khaksar; Farzaneh Vafaee; Fatemeh Forouzanfar; Sajad Sahab Negah
Journal:  Mol Biol Rep       Date:  2021-07-07       Impact factor: 2.316

Review 10.  Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.